Nrf2 is a key regulator of metabolism in cancer cells: Cancer cells acquire a resistance to oxidative, metabolic, and therapeutic insults through Nrf2/Keap1 signaling, which results in cytoprotective responses [124]. Here, KEAP1 is linked to cancer.